CG
GSK icon

Cutler Group’s GSK GSK Stock Holding History

Cutler Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,200
Closed -$8K – 2780
2023
Q4 		$8K Sell
5,200
-3,400
-40% -$122K ﹤0.01% 2518
2023
Q3 		$16K Buy
8,600
+5,800
+207% +$206K ﹤0.01% 2190
2023
Q2 		$1K Buy
2,800
+800
+40% +$28.7K ﹤0.01% 3286
2023
Q1 		$1K Sell
2,000
-2,100
-51% -$73.5K ﹤0.01% 3434
2022
Q4 		$5K Sell
4,100
-8,400
-67% -$280K ﹤0.01% 3172
2022
Q3 		$6K Sell
12,500
-12,220
-49% -$463K ﹤0.01% 3499
2022
Q2 		$31K Sell
24,720
-113,600
-82% -$6.27M ﹤0.01% 2302
2022
Q1 		$394K Buy
138,320
+135,680
+5,139% +$7.37M 0.02% 779
2021
Q4 		$3K Buy
+2,640
New +$137K ﹤0.01% 4509
2021
Q3 		– Sell
-15,040
Closed -$4K – 5947
2021
Q2 		$4K Buy
+15,040
New +$723K ﹤0.01% 4584
2020
Q3 		– Sell
-2,400
Closed -$3K – 4889
2020
Q2 		$3K Hold
2,400
– – ﹤0.01% 3608
2020
Q1 		$2K Buy
+2,400
New +$128K ﹤0.01% 3482
2018
Q3 		– Sell
-5,600
Closed -$11K – 4322
2018
Q2 		$11K Buy
5,600
+1,200
+27% +$60.4K ﹤0.01% 2601
2018
Q1 		$11K Buy
+4,400
New +$205K ﹤0.01% 2725
2017
Q4 		– Sell
-6,480
Closed -$2K – 5258
2017
Q3 		$2K Buy
6,480
+5,200
+406% +$264K ﹤0.01% 5070
2017
Q2 		$1K Sell
1,280
-2,960
-70% -$158K ﹤0.01% 5879
2017
Q1 		$15K Sell
4,240
-2,320
-35% -$118K ﹤0.01% 3623
2016
Q4 		$10K Buy
6,560
+6,480
+8,100% +$320K ﹤0.01% 4190
2016
Q3 		$2K Buy
+80
New +$4.39K ﹤0.01% 5689
2016
Q2 		– Sell
-23,200
Closed -$27K – 6872
2016
Q1 		$27K Buy
23,200
+9,520
+70% +$474K ﹤0.01% 2960
2015
Q4 		$3K Buy
+13,680
New +$697K ﹤0.01% 5283

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's GSK Position: Q1 2024 in Review

Cutler Group reduced its GSK (GSK) stake by 98% in Q1 2024, selling an estimated $438K and leaving 249 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Cutler Group first reported a position in GSK in Q4 2015 and has held it in 17 quarters since. The position peaked at $701K in Q3 2021. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Cutler Group held 249 shares of GSK worth $10K as of Q1 2024.
  • Cutler Group sold 10,622 GSK shares in Q1 2024, an estimated $438K.
  • GSK made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1273 holding.
  • Cutler Group first reported a position in GSK in Q4 2015 and has held it in 17 quarters since.
  • Cutler Group's GSK position peaked at $701K in Q3 2021.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.